Improving Aspirin Use Among Adults at Risk for Cardiovascular Disease (CVD)

NACompletedINTERVENTIONAL
Enrollment

884

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Cardiovascular Disease
Interventions
BEHAVIORAL

Pre-visit Summary

The intervention is a pre-visit summary given to the patient prior to their appointment. The pre-visit summary details the patient's risk of heart attack or stroke and the benefits of daily prophylactic aspirin use.

BEHAVIORAL

Clinical Decision Sharing Tool

This intervention includes a pre-visit summary and a clinical decision sharing tool. Patients will receive a pre-visit summary prior to their appointment. They will also view a clinical decision sharing tool in conjunction with the physician in the office. The pre-visit summary details the patient's risk of heart attack or stroke and the benefits of daily prophylactic aspirin use. The clinical decision sharing tool informs the physician of the patient's heart attack or stroke risk and determines if the patient would benefit from aspirin use.

Trial Locations (3)

16866

Geisinger Clinic - Moshannon Valley, Philipsburg

17044

Geisinger Clinic - Lewistown, Lewistown

18505

Geisinger Clinic - Lake Scranton, Scranton

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Agency for Healthcare Research and Quality (AHRQ)

FED

lead

Geisinger Clinic

OTHER